AccuVein, a provider of medical imaging solutions, has received $22.5m in a Series B financing from MVM Life Science Partners and Bessemer Venture Partners for its handheld, non-contact vein illumination device - AV300.
Subscribe to our email newsletter
The AV300 has been shown to improve peripheral vascular access for IV infusion by projecting a safe pattern of light on patient’s skin that reveals the position of underlying veins.
MVM partner Bednarski said they are excited to work with the company to improve patient care by making vein illumination broadly available to patients and clinicians.